Ferroptosis and noncoding RNAs: exploring mechanisms in lung cancer treatment
Nadi Rostami Ravari,
No information about this author
Farzad Sadri,
No information about this author
Mohammad Ali Mahdiabadi
No information about this author
et al.
Frontiers in Cell and Developmental Biology,
Journal Year:
2025,
Volume and Issue:
13
Published: Feb. 26, 2025
Lung
cancer
(LC)
is
a
highly
prevalent
and
deadly
type
of
characterized
by
intricate
molecular
pathways
that
drive
tumor
development,
metastasis,
resistance
to
conventional
treatments.
Recently,
ferroptosis,
controlled
mechanism
cell
death
instigated
iron-dependent
lipid
peroxidation,
has
gained
attention
for
its
role
in
LC
progression
treatment.
Noncoding
RNAs
(ncRNAs),
such
as
microRNAs
(miRNAs)
long
noncoding
(lncRNAs),
are
emerging
key
modulators
significantly
influencing
biology.
This
review
explores
how
ncRNAs
control
ferroptotic
affect
growth,
therapy
LC.
By
understanding
the
dual
functions
both
activating
inhibiting
we
aim
uncover
new
therapeutic
targets
strategies
These
insights
provide
promising
direction
development
ncRNA-based
treatments
designed
induce
potentially
improving
outcomes
patients
with
Language: Английский
Enhancing recovery in non-small cell lung cancer patients through mindfulness training and Jinshui Liujun decoction supplementation
World Journal of Psychiatry,
Journal Year:
2025,
Volume and Issue:
15(3)
Published: Feb. 26, 2025
This
article
delves
into
the
research
conducted
by
Liu
DW
et
al
on
integration
of
mindfulness-based
stress
reduction
training
(MSRT)
and
flavored
Jinshui
Liujun
decoction
(FJLD)
with
conventional
chemotherapy
(CC)
in
treatment
non-small
cell
lung
cancer.
The
study
investigates
impact
this
combined
approach
immune
function
emotional
well-being
cancer
patients.
Patients
were
divided
a
control
group
(CG)
receiving
CC
alone
(TG)
MSRT
+
FJLD
alongside
CC.
primary
outcomes
progression-free
survival
overall
survival,
secondary
including
Karnofsky
performance
status
scores,
clinical
efficacy,
markers,
state
assessments.
findings
underscore
significant
improvements
median
(20.50
months
TG
vs
13.10
CG,
P
<
0.05),
scores
(60
50
ratios,
along
reductions
negative
emotions
(self-rating
anxiety
scale
self-rating
depression
significantly
lower
TG,
0.05)
among
patients
conjunction
highlights
potential
combining
traditional
Chinese
medicine
modern
psychological
interventions
to
enhance
efficacy
treatments
improve
patient
outcomes.
Language: Английский
Lysosome-Targeting Chimera Using Mannose-6-Phosphate Glycans Derived from Glyco-Engineered Yeast
Seobin Kim,
No information about this author
Jiyeon Kang,
No information about this author
D.R. An
No information about this author
et al.
Bioconjugate Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
Lysosome-targeting
chimeras
(LYTACs)
harness
the
cell's
lysosomal
degradation
machinery
to
break
down
extracellular
and
membrane
proteins.
Previous
methods
used
a
synthetic
glycopeptide
containing
multiple
serine-O-mannose-6-phosphate
(poly-M6Pn),
which
presented
challenges
such
as
complexity
potential
immunogenicity
associated
with
poly-M6Pn.
This
study
introduced
LYTAC
formulation,
LYTACgyM6pG,
uses
glyco-engineered
yeast-derived
mannose-6-phosphate
glycans
(gyM6pGs)
for
transport,
overcoming
complexities
immunogenic
risks.
The
gyM6pGs
in
LYTACgyM6pG
are
human-compatible
(identical
structures
found
humans)
efficiently
produced
through
yeast
fermentation,
followed
by
preparation
of
cell
wall
their
vitro
modifications.
We
employed
copper-free
click
chemistry
(azide
dibenzocyclooctyne
reactions)
robust
conjugation
nanobody
targeting
immune
checkpoint
protein
PD-L1,
thereby
streamlining
assembly
LYTACgyM6pG.
demonstrated
that
effectively
degraded
endogenous
recombinant
PD-L1
proteins
on
surface
directing
them
lysosome
via
cation-independent
receptor
pathway.
Furthermore,
significantly
enhanced
T
cell-mediated
cytotoxicity
against
cancer
cells,
surpassing
efficacy
nanobodies
alone.
successful
application
development
highlights
more
viable
scalable
therapeutic
production
LYTACs,
paving
way
broader
applications,
including
treatment.
Language: Английский
A Biotin-selective Molecular Imprinted Polymer Containing Fe3O4 Nanoparticles and CD44-selective Aptamer for Targeting Cancer Hyperthermia Therapy
Feng‐Shuo Yang,
No information about this author
C. Hung,
No information about this author
Yu‐Lun Lo
No information about this author
et al.
Journal of Drug Delivery Science and Technology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 106972 - 106972
Published: April 1, 2025
Language: Английский
Unraveling the interplay of CD8 + T cells and microRNA signaling in cancer: implications for immune dysfunction and therapeutic approaches
Arefeh Zabeti Touchaei,
No information about this author
Sogand Vahidi
No information about this author
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Dec. 20, 2024
Language: Английский
Mindfulness-based stress reduction training and supplemented Jinshui Liujun decoction promote recovery in patients with non-small cell lung cancer
World Journal of Psychiatry,
Journal Year:
2024,
Volume and Issue:
14(12), P. 1876 - 1885
Published: Nov. 27, 2024
BACKGROUND
Conventional
chemotherapy
(CC)
administered
to
patients
with
non-small
cell
lung
cancer
(NSCLC)
often
causes
adverse
effects,
such
as
cardiopulmonary
dysfunction
and
immune
system
imbalance.
Patients
may
experience
anxiety
depression
during
the
perioperative
period
due
various
factors,
treatment
costs
recurrence
risks,
thereby
compromising
overall
quality
of
life.
Consequently,
we
hypothesized
that
integrating
mindfulness-based
stress
reduction
training
(MSRT)
Jinshui
Liujun
decoction
mitigate
negative
emotions
promote
recovery
in
NSCLC.
AIM
To
explore
effects
MSRT
on
function
emotional
state
NSCLC
patients.
METHODS
A
retrospective
clinical
study
was
conducted
involving
92
stage
IIIb-IV
NSCLC;
35
control
group
(CG)
received
CC
therapy
(combination
pemetrexed
carboplatin),
57
(TG)
MSRT-assisted
flavored
(FJLD)
addition
CC.
We
evaluated
survival
time,
Karnofsky
performance
status,
efficacy,
traditional
Chinese
medicine
syndrome
score,
function,
level,
reactions
CG
TG.
RESULTS
Median
progression-free
survival,
efficacy
TG
were
superior
those
(P
<
0.05).
Symptoms
cough,
weakness,
bloody
sputum,
shortness
breath,
chest
pain
significantly
decreased
compared
In
TG,
+
FJLD
increased
numbers
CD3+
CD4+
cells,
effectively
reduced
number
CD8+
enhanced
CD4+/CD8+
ratio,
restoring
self-rating
scale
scores
significantly.
There
no
statistically
significant
difference
incidence
between
>
CONCLUSION
proved
be
an
effective
for
Language: Английский